MIM
OYST

MetLife Investment Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

MetLife Investment Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,846
Closed -$99.6K – 2376
2020
Q1 		$99.6K Buy
+2,846
New +$92.1K ﹤0.01% 2081

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

MetLife Investment Management's OYST Position: Q2 2020 in Review

MetLife Investment Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2020, closing a stake of 2,846 shares — an estimated $99.6K sold.

MetLife Investment Management first reported a position in OYST in Q1 2020 and held it in 1 quarter. The position peaked at $99.6K in Q1 2020. 72 funds tracked by Wall St. Rank hold OYST as of Q2 2020.

  • MetLife Investment Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • MetLife Investment Management sold 2,846 Oyster Point Pharma, Inc. Common Stock shares in Q2 2020, an estimated $99.6K.
  • MetLife Investment Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • MetLife Investment Management's Oyster Point Pharma, Inc. Common Stock position peaked at $99.6K in Q1 2020.
  • 72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2020.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.